# NHLH2

## Overview
NHLH2, or nescient helix-loop-helix 2, is a gene that encodes a transcription factor involved in the regulation of energy balance, body weight, and reproductive functions. The protein product of NHLH2 is characterized by a basic helix-loop-helix (bHLH) domain, which facilitates its role in DNA binding and transcriptional regulation. This transcription factor is primarily active in the hypothalamus, where it responds to energy availability signals and participates in pathways such as leptin signaling. NHLH2 functions by binding to E-box motifs in DNA, often forming dimers that are crucial for its regulatory activities. The gene's expression and activity are modulated by post-translational modifications, including phosphorylation, which can influence its stability and function. Mutations in NHLH2 have been linked to clinical conditions such as idiopathic hypogonadotropic hypogonadism and obesity, highlighting its significance in maintaining normal physiological processes (Vella2007Expression; Madsen2023In; Fox2008Nescient).

## Structure
The NHLH2 protein is a transcription factor characterized by a basic helix-loop-helix (bHLH) domain, which is crucial for its function in DNA binding and transcriptional regulation (Madsen2023In). The primary structure of NHLH2 consists of 135 amino acids, with the protein-coding region contained within a single exon (Madsen2023In). The secondary structure includes a basic region and helix domains, which are essential for DNA binding through an E-box motif. Specific amino acids in the basic region and the first part of helix 1 are critical for DNA interaction (Madsen2023In).

The NHLH2 protein dimerizes with a partner to bind to the E-box motif, indicating a quaternary structure involving dimerization (Madsen2023In). Post-translational modifications of NHLH2 include phosphorylation, with predicted serine and threonine phosphorylation sites primarily located within the N-terminus (Madsen2023In). The protein also contains nuclear and nucleolar localization signals, suggesting its presence in the nucleus or nucleolus, aligning with its role in transcriptional regulation (Madsen2023In). Variants in the NHLH2 gene can introduce additional phosphorylation sites or affect glycosylation, impacting the protein's function and stability (Madsen2023In).

## Function
The NHLH2 gene encodes a transcription factor that plays a significant role in regulating energy balance, body weight, and reproductive functions in humans. It is primarily active in the hypothalamus, particularly in the paraventricular and arcuate nuclei, where it responds to energy availability signals (Vella2007Expression). NHLH2 is involved in the leptin signaling pathway, acting as a downstream target that influences the expression of genes such as prohormone convertase 1/3 (PC1/3) and thyrotropin-releasing hormone (TRH) (Vella2007Expression; Fox2008Nescient). 

The protein functions by binding to E-box motifs in the DNA, often forming heterodimers or homodimers through its helix-loop-helix domains, which are crucial for its role in transcriptional regulation (Madsen2023In). NHLH2's activity is modulated by post-translational modifications, including phosphorylation and acetylation, which can affect its function and stability (Madsen2023In). 

In healthy cells, NHLH2 is essential for maintaining normal body weight and reproductive health, as evidenced by its involvement in the regulation of the POMC-melanocortin pathway and its impact on neuropeptide synthesis (Topaloglu2022Inactivating). Its expression is influenced by nutritional status and leptin levels, highlighting its role as a sensor of peripheral energy signals (Vella2007Expression).

## Clinical Significance
Mutations in the NHLH2 gene are associated with several clinical conditions, primarily idiopathic hypogonadotropic hypogonadism (IHH) and obesity. Inactivating variants of NHLH2 have been identified in patients with these conditions, mirroring findings in Nhlh2 knockout mice that exhibit similar phenotypes (Topaloglu2022Inactivating). The gene's deficiency can lead to hypoactivity of the hypothalamic-pituitary-gonadal (HPG) axis, resulting in conditions such as cryptorchidism and microphallus in males (Topaloglu2022Inactivating). NHLH2 is also implicated in the pathogenesis of Prader-Willi Syndrome, where similar phenotypes are observed (Topaloglu2022Inactivating).

Specific missense variants, such as p.R79C and p.A83P, have been studied for their impact on DNA binding and transactivation, showing reduced binding to promoters crucial for metabolic and reproductive functions (Topaloglu2022Inactivating). These variants are predicted to be deleterious and contribute to the phenotype of IHH and obesity, potentially in combination with other genetic factors (Topaloglu2022Inactivating). The inheritance pattern of NHLH2-related conditions can be either autosomal recessive or dominant, with a noted male predilection in phenotypic expression (Topaloglu2022Inactivating).

## Interactions
NHLH2 (nescient helix-loop-helix 2) is a transcription factor that participates in various protein-protein and protein-DNA interactions. It interacts with the signal transducer and activator of transcription 3 (STAT3) to regulate the transcription of the prohormone convertase 1/3 (PC1/3) gene. This interaction involves the formation of a heterodimer between NHLH2 and STAT3, which binds to specific motifs on the PC1/3 promoter, facilitating transcriptional activation in response to leptin signaling (Fox2008Nescient).

NHLH2 also binds to E-box motifs on the PC1/3 promoter, which is crucial for its role in gene regulation. Chromatin Immunoprecipitation (ChIP) and Electrophoretic Mobility Shift Assays (EMSA) have demonstrated that NHLH2 specifically binds to these motifs, indicating a direct role in transcriptional regulation (Fox2008Nescient).

In addition to its interaction with STAT3, NHLH2 can form homodimers and heterodimers with other proteins, such as HES1, which can block transcriptional activity or form dimeric repressors (Torres-Machorro2021Homodimeric). NHLH2 is also capable of forming homodimers that function as transactivators through direct DNA binding (Torres-Machorro2021Homodimeric).


## References


[1. (Torres-Machorro2021Homodimeric) Ana Lilia Torres-Machorro. Homodimeric and heterodimeric interactions among vertebrate basic helix–loop–helix transcription factors. International Journal of Molecular Sciences, 22(23):12855, November 2021. URL: http://dx.doi.org/10.3390/ijms222312855, doi:10.3390/ijms222312855. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms222312855)

[2. (Vella2007Expression) K. R. Vella, A. S. Burnside, K. M. Brennan, and D. J. Good. Expression of the hypothalamic transcription factor nhlh2 is dependent on energy availability. Journal of Neuroendocrinology, 19(7):499–510, June 2007. URL: http://dx.doi.org/10.1111/j.1365-2826.2007.01556.x, doi:10.1111/j.1365-2826.2007.01556.x. This article has 29 citations and is from a peer-reviewed journal.](https://doi.org/10.1111/j.1365-2826.2007.01556.x)

[3. (Topaloglu2022Inactivating) A. Kemal Topaloglu, Enver Simsek, Matthew A. Kocher, Jamala Mammadova, Ece Bober, Leman Damla Kotan, Ihsan Turan, Can Celiloglu, Fatih Gurbuz, Bilgin Yuksel, and Deborah J. Good. Inactivating nhlh2 variants cause idiopathic hypogonadotropic hypogonadism and obesity in humans. Human Genetics, 141(2):295–304, January 2022. URL: http://dx.doi.org/10.1007/s00439-021-02422-9, doi:10.1007/s00439-021-02422-9. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00439-021-02422-9)

[4. (Madsen2023In) Allison T. Madsen and Deborah J. Good. In silico examination of single nucleotide missense mutations in nhlh2, a gene linked to infertility and obesity. International Journal of Molecular Sciences, 24(4):3193, February 2023. URL: http://dx.doi.org/10.3390/ijms24043193, doi:10.3390/ijms24043193. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms24043193)

[5. (Fox2008Nescient) Dana L. Fox and Deborah J. Good. Nescient helix-loop-helix 2 interacts with signal transducer and activator of transcription 3 to regulate transcription of prohormone convertase 1/3. Molecular Endocrinology, 22(6):1438–1448, June 2008. URL: http://dx.doi.org/10.1210/me.2008-0010, doi:10.1210/me.2008-0010. This article has 32 citations.](https://doi.org/10.1210/me.2008-0010)